Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Geuenich

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Biochemical Pharmacology|March 26, 1998
Induction of leukotriene production by bleomycin and asparaginase in mast cells in vitro and in patients in vivoS Geuenich, C Haberl, D Egger, et al.
Mediators of Inflammation|December 4, 1998
Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activityC Haberl, L Hültner, A Flügel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1995
IL-4 renders mast cells functionally responsive to endothelin-1D Egger, S Geuenich, C Denzlinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Weekly docetaxel (Taxotere) in patients with metastatic breast cancerH J Stemmler, K Gutschow, H Sommer, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Biochemical Pharmacology|March 26, 1998
Induction of leukotriene production by bleomycin and asparaginase in mast cells in vitro and in patients in vivoS Geuenich, C Haberl, D Egger, et al.
Mediators of Inflammation|December 4, 1998
Release of prostaglandin D2 by murine mast cells: importance of metabolite formation for antiproliferative activityC Haberl, L Hültner, A Flügel, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1995
IL-4 renders mast cells functionally responsive to endothelin-1D Egger, S Geuenich, C Denzlinger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Weekly docetaxel (Taxotere) in patients with metastatic breast cancerH J Stemmler, K Gutschow, H Sommer, et al.
Pageof 1